LIVN: LivaNova PLC

LIVN新闻

• 14:58 Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?
• 14:45 NPCE Explains How NeuroPace's RNS System Makes Money
• 14:34 NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care
• 16:00 LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know
• 11:25 LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
• 10:57 AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?
• 15:18 LivaNova Expands OSA Care With FDA-Approved aura6000 System
• 10:18 Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength?
• 13:35 Down 7.2% in 4 Weeks, Here's Why You Should You Buy the Dip in LivaNova (LIVN)
• 15:40 Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026
• 15:39 NPCE RNS System Explained: Growth Drivers and Setup for 2026
• 15:21 NeuroPace's Seizure ID and New Indication Could Expand RNS Demand
• 17:00 All You Need to Know About LivaNova (LIVN) Rating Upgrade to Buy
• 09:55 LivaNova: Excellent Performer Too Expensive In 2026 (Rating Downgrade) (NASDAQ:LIVN)
• 14:35 LivaNova stock hits 52-week high at $71.00
• 11:29 Wolfe Research上调Livanova股票目标价,看好癫痫业务前景
• 11:27 Wolfe Research raises Livanova stock price target on epilepsy outlook
• 21:37 Stifel上调LivaNova股票目标价至80美元,看好强劲增长
• 21:35 Stifel raises Livanova stock price target to $80 on strong growth
• 18:02 Needham上调Livanova目标价至81美元,因业绩强劲
• 18:00 Needham raises Livanova stock price target to $81 on strong results
• 17:30 LivaNova (LIVN) Reports Q4 Earnings: What Key Metrics Have to Say
• 17:15 LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates
• 11:33 LivaNova第四季度业绩强劲增长超预期